BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 8 July 1997
Acyclovir is the generic equivalent of the leading anti-viral drug, Zovirax. Acyclovir is indicated for the treatment of genital herpes, herpes zoster (shingles) and chicken pox. Glaxo Wellcome's Zovirax had total U.S. sales of $488 million in 1996. American Pharmaceutical Partners is currently awaiting approval of a ready-to-use I.V. formulation of acyclovir.
American Pharmaceutical Partners (APP), with headquarters in Santa Monica, is a subsidiary of VivoRx Pharmaceuticals Inc. (VPI), a member of the VivoRx group of companies. VPI is a development- stage biopharmaceutical company committed to the development and commercialization of therapeutics utilizing proprietary next generation delivery systems.
This agreement with Glaxo Wellcome, the world's largest pharmaceutical company, initiates APP's strategy to enter into collaborative agreements with major ethical pharmaceutical companies to market and distribute major proprietary drugs prior to or upon patent expiration.
The significant technical drug and gene-delivery proprietary platform of VPI provides an opportunity for line extensions of such products and the development of next generation proprietary therapeutics.
APP believes that the unique relationships it enjoys with large group purchasing organizations positions the company to gain significant market share of selected generic products.
Glaxo Wellcome is a research-based company committed to fighting disease by bringing innovative medicines and services to patients and the health care providers who serve them. Glaxo Wellcome Inc., a subsidiary of Glaxo Wellcome plc., is the nation's leading research-based pharmaceutical firm and has headquarters in Research Triangle Park, N.C.
American Pharmaceutical Partners is committed to being the leading company in the development, manufacture and marketing of proprietary and high-value injectable pharmaceutical products. APP has established contractual supply agreements with high-volume pharmaceutical purchasing organizations, including Premier, the country's largest group purchasing organization.
CONTACT: American Pharmaceutical Partners, Santa Monica Jeffrey Yordon, 310/264-7768 or VivoRx Pharmaceuticals Inc., Santa Monica Patrick Soon-Shiong, 310/264-7768
Copyright (c) 1997/BUSINESS WIRE. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854.
970708
BW970703
ÆGIS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.
ÆGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2003. AEGiS. All materials appearing on ÆGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of ÆGiS, or the party credited as the provider of the content.